Nucleic Acid Therapeutics Market Scope And Analysis

  • Report Code : TIPRE00027648
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analisi dell'ambito di mercato e dei concorrenti della terapia con acidi nucleici entro il 2025-2031

Buy Now

Nucleic Acid Therapeutics Market Report Nucleic Acid Therapeutics Market Size and Share Nucleic Acid Therapeutics Market Scope and Analysis

Nucleic Acid Therapeutics Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Tipo
  • spugna Antagomir e RNA
  • terapia oligonucleotide antisenso
  • acido nucleico bloccato
  • oligonucleotide peptidico dell'acido nucleico
  • terapia RNAi
  • oligonucleotide formante triplex.
By Applicazione
  • disturbi genetici
  • disturbi autoimmuni
By Utente finale
  • Istituti di ricerca
  • Ospedali e Cliniche.
By Geografia
  • America del Nord
  • Europa
  • Asia-Pacifico
  • America centrale e meridionale
Regions and Countries Covered Nord America
  • Stati Uniti
  • Canada
  • Messico
Europa
  • Regno Unito
  • Germania
  • Francia
  • Russia
  • Italia
  • Resto Europa
Asia-Pacifico
  • Cina
  • India
  • Giappone
  • Australia
  • resto delAsia-Pacifico
America centrale e meridionale
  • Brasile
  • Argentina
  • Resto delAmerica Centrale e Meridionale
Medio Oriente e Africa
  • Sudafrica
  • Arabia Saudita
  • Emirati Arabi Uniti
  • Resto del Medio Oriente e Africa
Market leaders and key company profiles
  • Alnylam Pharmaceuticals, Inc.
  • Silence Therapeutics plc
  • Arbutus Biopharma Corporation
  • Genzyme (Sanofi)
  • Ionis Pharmaceuticals
  • Sarepta Therapeutics
  • Benitec Biopharma Inc.
  • Arrowhead Pharmaceuticals
  • Biogen, Inc.